anti–mouse ifn-γ antibody Search Results


93
Miltenyi Biotec αifnγ
HPGDS expression in macrophages is sustained byprotumoral cytokines and is downmodulated by activated T cells. A, Violin plot comparing Hpgds expression between <t>Ifn</t> + and Mrc1 + macrophages, extracted from a publicly available scRNA-seq dataset. B, Hpgds expression assessed by qRT-PCR in monocytes (CD45 + , CD11b + , and CD115 + ) and TAMs (CD45 + , CD11b + , and F4/80 + ) from melanoma-bearing mice ( n = 3). C, qRT-PCR analysis of the expression of Hpgds in BMDMs Ctrl or stimulated with antitumoral stimuli (i.e., IFNγ with LPS), protumoral cytokines (i.e., IL-4, IL-6, and IL-10) or with IL-4 and after IL-4 washout, with antitumoral stimuli (e.g., TNFα, IFNγ, and LPS, alone or in combination; n = 3). D, Extracellular levels of PGD 2 measured by ELISA in BMDMs Ctrl or stimulated with IL-4 or first with IL-4 and then with TNFα ( n = 3). E, qRT-PCR analysis showing the regulation of Hpgds expression in IL-4–polarized BMDMs alone (Ctrl) or cocultured with preactivated CD8 + T cells or CD8 + T-cell CM with an isotype or <t>an</t> <t>αTNFα</t> blocking antibody ( n = 3–4). F and G, Tumor growth of resistant (YUMM 1.7; F ) vs. responsive (YUMMER 1.7; G ) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). H and I, Quantification ( H ) and representative images ( I ) of HPGDS + macrophages in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). J, Quantification of CD206 + immunosuppressive macrophages in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1 or the combination of αCD8 and αPD1 ( n = 3–4). K, Quantification of vessel density in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). L and M, Quantification ( L ) and representative images ( M ) of αSMA + pericyte blood vessel coverage of YUMM 1.7 or YUMMER 1.7 melanoma-bearing mice treated with IgG, αCD8, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). N, Tumor growth of YUMMER 1.7 melanoma-bearing mice treated with IgG, αPD1, or αPD1 combined with Enbrel ( n = 8–9). O, Quantification of F4/80 + macrophages in YUMMER 1.7 melanoma tumors treated with IgG, αPD1, or αPD1 in combination with Enbrel. In the group treated with αPD1, three out of nine tumors regressed completely; thus, the staining was not performed ( n = 6–9). P and Q, Quantification ( P ) and representative images ( Q ) of HPGDS + macrophages in YUMMER 1.7 melanoma tumors treated with IgG, αPD1, or αPD1 in combination with Enbrel. In the group treated with αPD1, three out of nine tumors regressed completely; thus, further analyses were not performed ( n = 6–9). P values are calculated by ( A) two-sided Wilcoxon test, ( B ) unpaired, two-tailed Student t test, ( C ) one-way ANOVA with Dunnett correction, and ( D , E , H , J , K , –L , O , and P ) one-way ANOVA with the Tukey multiple comparison test. F , G and N, two-way repeated measures ANOVA. Graphs show the mean ± SEM. I , L and Q, Scale bar: 20 μm.
αifnγ, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/IFN-%CE%B3+Antibody%2C+anti-mouse/pmc12223510-360-7-8
Average 93 stars, based on 1 article reviews
αifnγ - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Multi Sciences (Lianke) Biotech Co Ltd pe cy7 conjugated anti ifn γ
HPGDS expression in macrophages is sustained byprotumoral cytokines and is downmodulated by activated T cells. A, Violin plot comparing Hpgds expression between <t>Ifn</t> + and Mrc1 + macrophages, extracted from a publicly available scRNA-seq dataset. B, Hpgds expression assessed by qRT-PCR in monocytes (CD45 + , CD11b + , and CD115 + ) and TAMs (CD45 + , CD11b + , and F4/80 + ) from melanoma-bearing mice ( n = 3). C, qRT-PCR analysis of the expression of Hpgds in BMDMs Ctrl or stimulated with antitumoral stimuli (i.e., IFNγ with LPS), protumoral cytokines (i.e., IL-4, IL-6, and IL-10) or with IL-4 and after IL-4 washout, with antitumoral stimuli (e.g., TNFα, IFNγ, and LPS, alone or in combination; n = 3). D, Extracellular levels of PGD 2 measured by ELISA in BMDMs Ctrl or stimulated with IL-4 or first with IL-4 and then with TNFα ( n = 3). E, qRT-PCR analysis showing the regulation of Hpgds expression in IL-4–polarized BMDMs alone (Ctrl) or cocultured with preactivated CD8 + T cells or CD8 + T-cell CM with an isotype or <t>an</t> <t>αTNFα</t> blocking antibody ( n = 3–4). F and G, Tumor growth of resistant (YUMM 1.7; F ) vs. responsive (YUMMER 1.7; G ) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). H and I, Quantification ( H ) and representative images ( I ) of HPGDS + macrophages in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). J, Quantification of CD206 + immunosuppressive macrophages in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1 or the combination of αCD8 and αPD1 ( n = 3–4). K, Quantification of vessel density in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). L and M, Quantification ( L ) and representative images ( M ) of αSMA + pericyte blood vessel coverage of YUMM 1.7 or YUMMER 1.7 melanoma-bearing mice treated with IgG, αCD8, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). N, Tumor growth of YUMMER 1.7 melanoma-bearing mice treated with IgG, αPD1, or αPD1 combined with Enbrel ( n = 8–9). O, Quantification of F4/80 + macrophages in YUMMER 1.7 melanoma tumors treated with IgG, αPD1, or αPD1 in combination with Enbrel. In the group treated with αPD1, three out of nine tumors regressed completely; thus, the staining was not performed ( n = 6–9). P and Q, Quantification ( P ) and representative images ( Q ) of HPGDS + macrophages in YUMMER 1.7 melanoma tumors treated with IgG, αPD1, or αPD1 in combination with Enbrel. In the group treated with αPD1, three out of nine tumors regressed completely; thus, further analyses were not performed ( n = 6–9). P values are calculated by ( A) two-sided Wilcoxon test, ( B ) unpaired, two-tailed Student t test, ( C ) one-way ANOVA with Dunnett correction, and ( D , E , H , J , K , –L , O , and P ) one-way ANOVA with the Tukey multiple comparison test. F , G and N, two-way repeated measures ANOVA. Graphs show the mean ± SEM. I , L and Q, Scale bar: 20 μm.
Pe Cy7 Conjugated Anti Ifn γ, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/Anti-Mouse+IFN-%CE%B3/pm40725033-171-5-9
Average 94 stars, based on 1 article reviews
pe cy7 conjugated anti ifn γ - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Elabscience Biotechnology anti ifn γ apc
HPGDS expression in macrophages is sustained byprotumoral cytokines and is downmodulated by activated T cells. A, Violin plot comparing Hpgds expression between <t>Ifn</t> + and Mrc1 + macrophages, extracted from a publicly available scRNA-seq dataset. B, Hpgds expression assessed by qRT-PCR in monocytes (CD45 + , CD11b + , and CD115 + ) and TAMs (CD45 + , CD11b + , and F4/80 + ) from melanoma-bearing mice ( n = 3). C, qRT-PCR analysis of the expression of Hpgds in BMDMs Ctrl or stimulated with antitumoral stimuli (i.e., IFNγ with LPS), protumoral cytokines (i.e., IL-4, IL-6, and IL-10) or with IL-4 and after IL-4 washout, with antitumoral stimuli (e.g., TNFα, IFNγ, and LPS, alone or in combination; n = 3). D, Extracellular levels of PGD 2 measured by ELISA in BMDMs Ctrl or stimulated with IL-4 or first with IL-4 and then with TNFα ( n = 3). E, qRT-PCR analysis showing the regulation of Hpgds expression in IL-4–polarized BMDMs alone (Ctrl) or cocultured with preactivated CD8 + T cells or CD8 + T-cell CM with an isotype or <t>an</t> <t>αTNFα</t> blocking antibody ( n = 3–4). F and G, Tumor growth of resistant (YUMM 1.7; F ) vs. responsive (YUMMER 1.7; G ) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). H and I, Quantification ( H ) and representative images ( I ) of HPGDS + macrophages in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). J, Quantification of CD206 + immunosuppressive macrophages in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1 or the combination of αCD8 and αPD1 ( n = 3–4). K, Quantification of vessel density in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). L and M, Quantification ( L ) and representative images ( M ) of αSMA + pericyte blood vessel coverage of YUMM 1.7 or YUMMER 1.7 melanoma-bearing mice treated with IgG, αCD8, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). N, Tumor growth of YUMMER 1.7 melanoma-bearing mice treated with IgG, αPD1, or αPD1 combined with Enbrel ( n = 8–9). O, Quantification of F4/80 + macrophages in YUMMER 1.7 melanoma tumors treated with IgG, αPD1, or αPD1 in combination with Enbrel. In the group treated with αPD1, three out of nine tumors regressed completely; thus, the staining was not performed ( n = 6–9). P and Q, Quantification ( P ) and representative images ( Q ) of HPGDS + macrophages in YUMMER 1.7 melanoma tumors treated with IgG, αPD1, or αPD1 in combination with Enbrel. In the group treated with αPD1, three out of nine tumors regressed completely; thus, further analyses were not performed ( n = 6–9). P values are calculated by ( A) two-sided Wilcoxon test, ( B ) unpaired, two-tailed Student t test, ( C ) one-way ANOVA with Dunnett correction, and ( D , E , H , J , K , –L , O , and P ) one-way ANOVA with the Tukey multiple comparison test. F , G and N, two-way repeated measures ANOVA. Graphs show the mean ± SEM. I , L and Q, Scale bar: 20 μm.
Anti Ifn γ Apc, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/APC+Anti-Mouse+IFN-%CE%B3+Antibody/pmc12126593-245-30-64
Average 94 stars, based on 1 article reviews
anti ifn γ apc - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Elabscience Biotechnology ifnγ
Fig. 8. Inhibition of NECTIN2 expression in ID8 cells can promote <t>the</t> <t>cytotoxic</t> function of co-cultured CTLs. a The expressions of PD1, PRF1 and <t>IFNγ</t> in CTLs cocultured with ID8 cells were detected by flow cytometry, n = 3. b-d Histogram plots show the proportion of PD1+ CTLs (b), PRF1+ CTLs (c) and IFNγ+ CTLs (d) in all CTLs co-cultured with ID8 cells in each group, n = 3.
Ifnγ, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/FITC+Anti-Mouse+IFN-%CE%B3+Antibody/pm39278093-100-59-65
Average 94 stars, based on 1 article reviews
ifnγ - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
Cytek Biosciences pe cy7ifnγ
Fig. 8. Inhibition of NECTIN2 expression in ID8 cells can promote <t>the</t> <t>cytotoxic</t> function of co-cultured CTLs. a The expressions of PD1, PRF1 and <t>IFNγ</t> in CTLs cocultured with ID8 cells were detected by flow cytometry, n = 3. b-d Histogram plots show the proportion of PD1+ CTLs (b), PRF1+ CTLs (c) and IFNγ+ CTLs (d) in all CTLs co-cultured with ID8 cells in each group, n = 3.
Pe Cy7ifnγ, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/PE-Cyanine7+Anti-Mouse+IFN+gamma/pm40175501-201-47-49
Average 92 stars, based on 1 article reviews
pe cy7ifnγ - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Cytek Biosciences anti mouse ifn γ
Fig. 8. Inhibition of NECTIN2 expression in ID8 cells can promote <t>the</t> <t>cytotoxic</t> function of co-cultured CTLs. a The expressions of PD1, PRF1 and <t>IFNγ</t> in CTLs cocultured with ID8 cells were detected by flow cytometry, n = 3. b-d Histogram plots show the proportion of PD1+ CTLs (b), PRF1+ CTLs (c) and IFNγ+ CTLs (d) in all CTLs co-cultured with ID8 cells in each group, n = 3.
Anti Mouse Ifn γ, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/APC+Anti-Mouse+IFN+gamma/pmc11040375-229-127-162
Average 93 stars, based on 1 article reviews
anti mouse ifn γ - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cytek Biosciences anti mouse ifn γ fitc
Fig. 8. Inhibition of NECTIN2 expression in ID8 cells can promote <t>the</t> <t>cytotoxic</t> function of co-cultured CTLs. a The expressions of PD1, PRF1 and <t>IFNγ</t> in CTLs cocultured with ID8 cells were detected by flow cytometry, n = 3. b-d Histogram plots show the proportion of PD1+ CTLs (b), PRF1+ CTLs (c) and IFNγ+ CTLs (d) in all CTLs co-cultured with ID8 cells in each group, n = 3.
Anti Mouse Ifn γ Fitc, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/FITC+Anti-Mouse+IFN+gamma/pmc12441315-802-0-7
Average 93 stars, based on 1 article reviews
anti mouse ifn γ fitc - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Miltenyi Biotec anti ifnγ fitc reafinitytm
Fig. 8. Inhibition of NECTIN2 expression in ID8 cells can promote <t>the</t> <t>cytotoxic</t> function of co-cultured CTLs. a The expressions of PD1, PRF1 and <t>IFNγ</t> in CTLs cocultured with ID8 cells were detected by flow cytometry, n = 3. b-d Histogram plots show the proportion of PD1+ CTLs (b), PRF1+ CTLs (c) and IFNγ+ CTLs (d) in all CTLs co-cultured with ID8 cells in each group, n = 3.
Anti Ifnγ Fitc Reafinitytm, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/IFN-%CE%B3+Antibody%2C+anti-mouse%2C+REAfinity/pm41620516-224-3-6
Average 95 stars, based on 1 article reviews
anti ifnγ fitc reafinitytm - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
MedChemExpress anti ifn treatments mice
Fig. 8. Inhibition of NECTIN2 expression in ID8 cells can promote <t>the</t> <t>cytotoxic</t> function of co-cultured CTLs. a The expressions of PD1, PRF1 and <t>IFNγ</t> in CTLs cocultured with ID8 cells were detected by flow cytometry, n = 3. b-d Histogram plots show the proportion of PD1+ CTLs (b), PRF1+ CTLs (c) and IFNγ+ CTLs (d) in all CTLs co-cultured with ID8 cells in each group, n = 3.
Anti Ifn Treatments Mice, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/Anti-Mouse+IFN+gamma+Antibody/pm42174265-415-3-16
Average 94 stars, based on 1 article reviews
anti ifn treatments mice - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Boster Bio il 18
Fig. 8. Inhibition of NECTIN2 expression in ID8 cells can promote <t>the</t> <t>cytotoxic</t> function of co-cultured CTLs. a The expressions of PD1, PRF1 and <t>IFNγ</t> in CTLs cocultured with ID8 cells were detected by flow cytometry, n = 3. b-d Histogram plots show the proportion of PD1+ CTLs (b), PRF1+ CTLs (c) and IFNγ+ CTLs (d) in all CTLs co-cultured with ID8 cells in each group, n = 3.
Il 18, supplied by Boster Bio, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/Anti-Mouse+IL-18+Antibody/pmc07587563-117-4-11
Average 96 stars, based on 1 article reviews
il 18 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Elabscience Biotechnology phycoerythrin pe anti mouse ifn γ
Fig. 8. Inhibition of NECTIN2 expression in ID8 cells can promote <t>the</t> <t>cytotoxic</t> function of co-cultured CTLs. a The expressions of PD1, PRF1 and <t>IFNγ</t> in CTLs cocultured with ID8 cells were detected by flow cytometry, n = 3. b-d Histogram plots show the proportion of PD1+ CTLs (b), PRF1+ CTLs (c) and IFNγ+ CTLs (d) in all CTLs co-cultured with ID8 cells in each group, n = 3.
Phycoerythrin Pe Anti Mouse Ifn γ, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/PE+Anti-Mouse+IFN-%CE%B3+Antibody/pmc09644205-72-24-33
Average 94 stars, based on 1 article reviews
phycoerythrin pe anti mouse ifn γ - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


HPGDS expression in macrophages is sustained byprotumoral cytokines and is downmodulated by activated T cells. A, Violin plot comparing Hpgds expression between Ifn + and Mrc1 + macrophages, extracted from a publicly available scRNA-seq dataset. B, Hpgds expression assessed by qRT-PCR in monocytes (CD45 + , CD11b + , and CD115 + ) and TAMs (CD45 + , CD11b + , and F4/80 + ) from melanoma-bearing mice ( n = 3). C, qRT-PCR analysis of the expression of Hpgds in BMDMs Ctrl or stimulated with antitumoral stimuli (i.e., IFNγ with LPS), protumoral cytokines (i.e., IL-4, IL-6, and IL-10) or with IL-4 and after IL-4 washout, with antitumoral stimuli (e.g., TNFα, IFNγ, and LPS, alone or in combination; n = 3). D, Extracellular levels of PGD 2 measured by ELISA in BMDMs Ctrl or stimulated with IL-4 or first with IL-4 and then with TNFα ( n = 3). E, qRT-PCR analysis showing the regulation of Hpgds expression in IL-4–polarized BMDMs alone (Ctrl) or cocultured with preactivated CD8 + T cells or CD8 + T-cell CM with an isotype or an αTNFα blocking antibody ( n = 3–4). F and G, Tumor growth of resistant (YUMM 1.7; F ) vs. responsive (YUMMER 1.7; G ) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). H and I, Quantification ( H ) and representative images ( I ) of HPGDS + macrophages in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). J, Quantification of CD206 + immunosuppressive macrophages in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1 or the combination of αCD8 and αPD1 ( n = 3–4). K, Quantification of vessel density in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). L and M, Quantification ( L ) and representative images ( M ) of αSMA + pericyte blood vessel coverage of YUMM 1.7 or YUMMER 1.7 melanoma-bearing mice treated with IgG, αCD8, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). N, Tumor growth of YUMMER 1.7 melanoma-bearing mice treated with IgG, αPD1, or αPD1 combined with Enbrel ( n = 8–9). O, Quantification of F4/80 + macrophages in YUMMER 1.7 melanoma tumors treated with IgG, αPD1, or αPD1 in combination with Enbrel. In the group treated with αPD1, three out of nine tumors regressed completely; thus, the staining was not performed ( n = 6–9). P and Q, Quantification ( P ) and representative images ( Q ) of HPGDS + macrophages in YUMMER 1.7 melanoma tumors treated with IgG, αPD1, or αPD1 in combination with Enbrel. In the group treated with αPD1, three out of nine tumors regressed completely; thus, further analyses were not performed ( n = 6–9). P values are calculated by ( A) two-sided Wilcoxon test, ( B ) unpaired, two-tailed Student t test, ( C ) one-way ANOVA with Dunnett correction, and ( D , E , H , J , K , –L , O , and P ) one-way ANOVA with the Tukey multiple comparison test. F , G and N, two-way repeated measures ANOVA. Graphs show the mean ± SEM. I , L and Q, Scale bar: 20 μm.

Journal: Cancer Discovery

Article Title: Activated T Cells Break Tumor Immunosuppression by Macrophage Reeducation

doi: 10.1158/2159-8290.CD-24-0415

Figure Lengend Snippet: HPGDS expression in macrophages is sustained byprotumoral cytokines and is downmodulated by activated T cells. A, Violin plot comparing Hpgds expression between Ifn + and Mrc1 + macrophages, extracted from a publicly available scRNA-seq dataset. B, Hpgds expression assessed by qRT-PCR in monocytes (CD45 + , CD11b + , and CD115 + ) and TAMs (CD45 + , CD11b + , and F4/80 + ) from melanoma-bearing mice ( n = 3). C, qRT-PCR analysis of the expression of Hpgds in BMDMs Ctrl or stimulated with antitumoral stimuli (i.e., IFNγ with LPS), protumoral cytokines (i.e., IL-4, IL-6, and IL-10) or with IL-4 and after IL-4 washout, with antitumoral stimuli (e.g., TNFα, IFNγ, and LPS, alone or in combination; n = 3). D, Extracellular levels of PGD 2 measured by ELISA in BMDMs Ctrl or stimulated with IL-4 or first with IL-4 and then with TNFα ( n = 3). E, qRT-PCR analysis showing the regulation of Hpgds expression in IL-4–polarized BMDMs alone (Ctrl) or cocultured with preactivated CD8 + T cells or CD8 + T-cell CM with an isotype or an αTNFα blocking antibody ( n = 3–4). F and G, Tumor growth of resistant (YUMM 1.7; F ) vs. responsive (YUMMER 1.7; G ) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). H and I, Quantification ( H ) and representative images ( I ) of HPGDS + macrophages in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). J, Quantification of CD206 + immunosuppressive macrophages in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1 or the combination of αCD8 and αPD1 ( n = 3–4). K, Quantification of vessel density in resistant (YUMM 1.7) vs. responsive (YUMMER 1.7) melanoma tumors treated with IgG control, αCD8 antibody, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). L and M, Quantification ( L ) and representative images ( M ) of αSMA + pericyte blood vessel coverage of YUMM 1.7 or YUMMER 1.7 melanoma-bearing mice treated with IgG, αCD8, αPD1, or the combination of αCD8 and αPD1 ( n = 3–4). N, Tumor growth of YUMMER 1.7 melanoma-bearing mice treated with IgG, αPD1, or αPD1 combined with Enbrel ( n = 8–9). O, Quantification of F4/80 + macrophages in YUMMER 1.7 melanoma tumors treated with IgG, αPD1, or αPD1 in combination with Enbrel. In the group treated with αPD1, three out of nine tumors regressed completely; thus, the staining was not performed ( n = 6–9). P and Q, Quantification ( P ) and representative images ( Q ) of HPGDS + macrophages in YUMMER 1.7 melanoma tumors treated with IgG, αPD1, or αPD1 in combination with Enbrel. In the group treated with αPD1, three out of nine tumors regressed completely; thus, further analyses were not performed ( n = 6–9). P values are calculated by ( A) two-sided Wilcoxon test, ( B ) unpaired, two-tailed Student t test, ( C ) one-way ANOVA with Dunnett correction, and ( D , E , H , J , K , –L , O , and P ) one-way ANOVA with the Tukey multiple comparison test. F , G and N, two-way repeated measures ANOVA. Graphs show the mean ± SEM. I , L and Q, Scale bar: 20 μm.

Article Snippet: When indicated, 25 μg/mL αTNFα, 20 μg/mL αIFNγ (Miltenyi Biotech, 130-095-729), or isotype Ctrl were added to the medium.

Techniques: Expressing, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Blocking Assay, Control, Staining, Two Tailed Test, Comparison

Fig. 8. Inhibition of NECTIN2 expression in ID8 cells can promote the cytotoxic function of co-cultured CTLs. a The expressions of PD1, PRF1 and IFNγ in CTLs cocultured with ID8 cells were detected by flow cytometry, n = 3. b-d Histogram plots show the proportion of PD1+ CTLs (b), PRF1+ CTLs (c) and IFNγ+ CTLs (d) in all CTLs co-cultured with ID8 cells in each group, n = 3.

Journal: Biochemical and biophysical research communications

Article Title: Immune escape between endoplasmic reticulum stress-related cancer cells and exhausted CD8+T cells leads to neoadjuvant chemotherapy resistance in ovarian cancer.

doi: 10.1016/j.bbrc.2024.150686

Figure Lengend Snippet: Fig. 8. Inhibition of NECTIN2 expression in ID8 cells can promote the cytotoxic function of co-cultured CTLs. a The expressions of PD1, PRF1 and IFNγ in CTLs cocultured with ID8 cells were detected by flow cytometry, n = 3. b-d Histogram plots show the proportion of PD1+ CTLs (b), PRF1+ CTLs (c) and IFNγ+ CTLs (d) in all CTLs co-cultured with ID8 cells in each group, n = 3.

Article Snippet: The transfected ID8 cells were co-cultured with the CTLs following stimulation by 8.5 μM cisplatin or the same volume of PBS (control group) for 24 h. CTLs in the supernatant were collected and the expression of depletion marker PD1(PE/DazzleTM 594 anti-mouse CD279 (PD1) Antibody, 109116, Biolegend, USA) and cytotoxic marker PRF1 (APC anti-mouse Perforin Antibody, 154304, Biolegend, USA) and IFNγ (FITC Anti-Mouse IFNγ Antibody, E-AB-F1101UC, elabscience, China) were detected by flow cytometry.

Techniques: Inhibition, Expressing, Cell Culture, Flow Cytometry